The company's shares rose as investors breathed a sigh of relief on strong sales growth and guidance, despite ongoing ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback